Delivery Order SPE2DB20D1110-SPE2DB24FK05C
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $1,585.87 order is for the supply of LINZESS 145 MCG capsules to support military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999 and a performance period through December 31, 2025. This IDC serves as the primary...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution services company. The contract is for the delivery of LINZESS 290 MCG capsules, with a ceiling value of $1,056.42 and a performance period through February 9, 2022. AmerisourceBergen Drug Corp serves as the prime contractor, providing pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to supply Linzess 145 MCG capsules. The contract has a ceiling value of $2,836.01 and runs through August 8, 2024. It is a firm fixed-price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a comprehensive range of medical...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor. The award is for the pharmaceutical product LINZESS 145 MCG CAPSULE in 30-count units, with a ceiling value of $2,635.63 and a performance period through April 5, 2024. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, specializes in providing pharmaceuticals and medical...
- The U.S. Defense Logistics Agency (DLA) has awarded a $13,368.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp, a division of the parent company Cencora, Inc. The contract is for the delivery of LINZESS 145 MCG capsules and does not have a set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025, which enables the DLA to efficiently procure a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $1,406.72 contract is for the supply of LINZESS 145MCG 30S, a pharmaceutical product, in support of military treatment programs and facilities. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation associated with this award. This delivery order is issued under an...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of LINZESS 145 MCG capsules to DLA Troop Support Medical, with a ceiling value of $1,198.63 and a performance period through April 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of LINZESS 145 MCG capsules. The contract has a firm fixed price of $4,196.85 and a period of performance through August 15, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at up to $999,999,999, for delivering a wide range of pharmaceutical and medical supplies to support military...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,252.62 delivery order is for the supply of Linzess 72 MCG capsules for the Department of Defense. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp with a potential value of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 145 mcg LINZESS capsules. The contract has a ceiling value of $1,889.28 and a period of performance ending on June 30, 2022. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB24FK05CDelivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $2,354.39, is for the delivery of LINZESS 145 MCG capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor, with its parent company being Cencora, Inc. doing business as AmerisourceBergen.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 3/20/24 |